Globus Medical (GMED) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Executive summary
Annual meeting scheduled for June 3, 2026, at 6:00 p.m. ET in Audubon, PA, with voting available online or in person.
Proxy materials, including the Notice, Proxy Statement, and Form 10-K, are accessible online or by request before May 20, 2026.
Voting matters and shareholder proposals
Election of two Class II directors to serve until the 2029 Annual Meeting.
Proposal to amend the 2021 Equity Incentive Plan, increasing authorized shares by 1,000,000.
Ratification of Deloitte & Touche LLP as independent auditor for the year ending December 31, 2026.
Advisory vote on 2025 executive compensation (Say-on-Pay).
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees Robert Douglas and Keith W. Pfeil.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Globus Medical
- Proxy covers director elections, equity plan amendment, auditor ratification, and executive pay.GMED
Proxy filing24 Apr 2026 - Record 2025 growth, raised 2026 EPS guidance, and strong cash flow driven by spine and tech.GMED
Q4 202525 Feb 2026 - Q2 net sales jumped 115.9% to $629.7M, with raised 2024 guidance and strong integration progress.GMED
Q2 20242 Feb 2026 - Q3 net sales up 63% to $625.7M, with record EPS and raised 2024 guidance.GMED
Q3 202416 Jan 2026 - Integration, innovation, and strategic acquisitions drive growth in robotics and spine care.GMED
CG 2025 Musculoskeletal Conference20 Dec 2025 - Record sales and profitability in 2024 set the stage for continued growth in 2025.GMED
Q4 202411 Dec 2025 - Proxy covers director elections, equity plan changes, auditor ratification, and executive pay votes.GMED
Proxy Filing1 Dec 2025 - Annual meeting seeks approval for directors, equity plan, auditor, and executive pay.GMED
Proxy Filing1 Dec 2025 - Q2 net sales up 18.4% to $745.3M, GAAP net income $202.8M, and record non-GAAP EPS.GMED
Q2 202523 Nov 2025